• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1990 Fiscal Year Final Research Report Summary

Mechanisms and Control of Proto-Oncogene Expression in Atherosclerosis in HYpertension.

Research Project

Project/Area Number 01570502
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Circulatory organs internal medicine
Research InstitutionOsaka City University Medical School

Principal Investigator

KANAYAMA Yoshiharu  Osaka City University Medical School Lecturer, 医学部, 講師 (60106341)

Co-Investigator(Kenkyū-buntansha) NEGORO Nobuo  Osaka City University Research Associate, 医学部, 助手 (80180701)
OKAMURA Mikio  Osaka City University Research Associate, 医学部, 助手 (90169144)
Project Period (FY) 1989 – 1990
Keywordsspontaneously hypertensive rats / c-myc / PDGF / EGF / angiotensinII / endothelin / inositol-1, 4, 5-triphosphate
Research Abstract

1. We found that growth factors such as fetal calf serum, platelet-derived growth factor, epidermal growth factor, angiotensin II, endothelin-1, endothelin-2 and endothelin-3 were inducible of an enhanced increase of c-myc mRNA in vascular smooth muscle cells from spontaneously hypertensive rats as compared with that from Wistar-Kyoto rats. However, transforming growth factor-beta1 did not induce c-myc gene expression. Calcium antagonists such as nifedipine and diltiazem, were able to inhibit the enhanced c-myc gene expression and DNA synthesis induced by growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.
2. We examined angiotensin II (ANGII) induced changes of inositol-1, 4, 5-triphosphate (Ins (1, 4, 5) P_3) in cultured vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) using a specific protein binding assay system. We observed a rapid biphasic Ins (1, 4, 5) P_3 response peaked at 5 and 30 seconds after ANGII stimulation. At every period of time the Ins (1, 4, 5) P_3 level of SHR was two to five fold higher than that of WKY. Thus, the assay specific for Ins (1, 4, 5) P_3 revealed complex 1ms (1, 4, 5) P_3 response after ANGII stimulation and suggested a need for further studies on the Ins (1, 4, 5) P_3 metabolism following agonist stimulation in VSMC. The enhanced Ins (1, 4, 5) P_3 response in VSMC from SHR may contribute the enhanced expression of c-myc gene in VSMC from SHR.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Nogoro N, Inariba H, Inoue T, Kanayama Y, Takeda T.: "Expression of cーmyc protooncogene in heart and cultured smooth musle cells of spontaneously hypertensive rats." J. Hypprtension. 6(suppl4). S128-S130 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 根来 伸夫,金山 良春,稲荷場 ひろみ,高析 和男,井上 隆智,武田 忠直: "高血圧自然発症ラット由来の培養血管平滑筋細胞におけるcーmyc遺伝子のエンドセリンによる発現調節" 高血圧. 12. 75 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 根来 伸夫,金山 良春,高析 和男,藤沢 美井子,岡村 幹夫,井上 隆智,稲荷場 ひろみ,武田 忠直: "高血圧自然発症ラット由来血管平滑筋細胞における癌原遺伝子発現の塩酸ブナゾシンによる抑制" 医学のあゆみ. 149. 721-722 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 根来 伸夫,稲荷場 ひろみ,美垂 真由美,高析 和男,井上 隆智,金山 良春,武田 忠直: "Ca拮抗薬による血管手滑筋細胞のcーmyc癌原遺伝子発現の抑制" 薬理と治療. 18. S221-S222 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Negoro N, Inarba H, Okanura M, Inoue T, Kanayama Y, Taleda T.: "Nifeelipine inhibited expression of cーmyc protoーoncogeue in cultured aortic smooth murle cdlls of spontaueously hypatensine rats" corculation. 78. II-4 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Negora N, Kanayama Y, Inaスiba H, Okamura M, Inoue T, Takeda T.: "Endothelin modulated cーmyc pratoーoncogeue expression in culturd uortic smooth mescle cells from spontareously hypatemsie rats." Hypertenscon. 14. 340-341 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Negoro N, Inariba H, Inoue T, Kanayama Y, Takeda T: "Expression of c-myc proto-oncogene in hearts and cultured smooth muscl cells of spontaneously hypertensive rats" J. Hypertension. 6. S128-S130 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Negoro N, Kanayama Y, Inariba H, Takaori K, Inoue T, Takeda T: "Modulation of c-myc proto-oncogene expression in vascular smooth muscle cells from spontaneously hypertensive rats with endothelin." Jpn. J. Hypertension. 12. 75 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Negoro N, Kanayama Y, Takaori K, Fujisawa M, Okamura M, Inoue T, Inariba H, Takeda T: "Inhibition of proto-oncogene expression in vascular smooth muscle cells from spontaneously hypertensive rats with bunazosin." Igaku-no Ayumi. 149. 721-722 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Negoro N, Inariba H, Minami M, Takaori K, Inoue T, Kanayama Y, Takeda T: "Inhibition of proto-oncogene expression in vascular smooth muscle cells with calcium antagonists." Yakuri to Chiryo. 18. S221-S222 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Negoro N, Inariba H, Okamura M, Inoue T, Kanayama Y, Takeda T: "Nifedipine inhibited expression of c-myc proto-oncogene in cultured aortic smooth muscle cells of spontaneously hypertensive rats." Circulation. 78. II-4 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Negoro N, Kanayama Y, Inariba H, Okamura M, Inoue T, Takeda T: "Endothelin modulated c-myc proto-oncogen expression in cultured aortic smooth muscle cells from spontaneously hypertensive rats" Hypertension. 14. 340 (1989)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-08-12  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi